Literature DB >> 2423429

Hepatitis B virus pre-S gene-encoded antigenic specificity and anti-pre-S antibody: relationship between anti-pre-S response and recovery.

A Budkowska, P Dubreuil, F Capel, J Pillot.   

Abstract

A solid-phase radioimmunoassay involving specific antibody was developed for determination of the pre-S gene-encoded epitopes of hepatitis B virus and anti-pre-S antibody in sera of hepatitis B patients. The reaction for pre-S determinants associated with HBsAg was quantitatively inhibited by soluble, polymerized human serum albumin, and the lower limit of the assay was about 1.6 ng of HBsAg per ml. Continuous expression of pre-S-coded antigenic sites on HBsAg particles in chronic hepatitis B patients seropositive for HBeAg or anti-HBe shows that these determinants may be considered as a marker of chronicity during hepatitis B virus infection. The anti-pre-S antibody was determined by inhibition of the reaction for pre-S determinants. This antibody, different from anti-HBs, was detected during HBsAg antigenemia in patients recovering from acute type B hepatitis, before anti-HBs response. Kinetics of synthesis of anti-pre-S antibody in the course of acute type B hepatitis, followed by elimination of HBsAg and recovery, suggest the possible role of this antibody in the immunological clearance of infective hepatitis B virus particles.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2423429     DOI: 10.1002/hep.1840060305

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  12 in total

1.  Expression and characterization of the multiplied, recombinant preS1 antigen of hepatitis B virus.

Authors:  M Sidorkiewicz; G Płucienniczak; A Płucienniczak
Journal:  Arch Virol       Date:  1995       Impact factor: 2.574

2.  Frequency of concurrence of hepatitis B surface antigen and antibody in a large number of carriers in Okinawa, Japan.

Authors:  J Hayashi; A Noguchi; K Nakashima; M Morofuji; S Kashiwagi
Journal:  Gastroenterol Jpn       Date:  1990-10

Review 3.  The humoral immune response in acute and chronic hepatitis B virus infection.

Authors:  D R Milich; M Sallberg; T Maruyama
Journal:  Springer Semin Immunopathol       Date:  1995

4.  Immunogenicity of a recombinant Pre-S2-containing hepatitis B vaccine versus plasma-derived vaccine administered as a booster.

Authors:  B Bucher; P Francioli; B Geudelin; B Fritzell; D Lavanchy; P C Frei
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1994-03       Impact factor: 3.267

5.  Changes of pre-S1 and pre-S2 antigens in sera of patients with hepatitis B virus infection.

Authors:  Y Iwasaki; K Matsuura; T Tsuji
Journal:  Gastroenterol Jpn       Date:  1990-08

6.  Electron microscopic study of hepatitis B virus-associated antigens on the infected liver cell membrane in relation to analysis of immune target antigens in chronic hepatitis B.

Authors:  T Saito; T Kamimura; M Ishibashi; H Shinzawa; T Takahashi
Journal:  Gastroenterol Jpn       Date:  1992-12

Review 7.  Immunology of hepatitis B virus infections.

Authors:  K H Heermann; W H Gerlich
Journal:  Rheumatol Int       Date:  1989       Impact factor: 2.631

8.  In vitro immune responses to hepatitis B surface antigen (Pre-S2 and S) following remote infection by hepatitis B virus in humans.

Authors:  T R Cupps; J H Hoofnagle; R W Ellis; W J Miller; L Seeff; A Guerrera; J L Gerin; S A Haas-Smith
Journal:  J Clin Immunol       Date:  1989-05       Impact factor: 8.317

9.  Human liver plasma membranes contain receptors for the hepatitis B virus pre-S1 region and, via polymerized human serum albumin, for the pre-S2 region.

Authors:  P Pontisso; M A Petit; M J Bankowski; M E Peeples
Journal:  J Virol       Date:  1989-05       Impact factor: 5.103

10.  The preS1 antigen of hepatitis B virus is highly immunogenic at the T cell level in man.

Authors:  C Ferrari; A Penna; A Bertoletti; A Cavalli; A Valli; C Schianchi; F Fiaccadori
Journal:  J Clin Invest       Date:  1989-10       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.